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Abstract 
POU3F2, also known as BRN2, Oct7, and N-Oct3, 
is a member of the neural cell-specific class III 
POU domain transcription factors (Ryan and 
Rosenfeld, 1997). POU3F2-knockout causes the 
loss of specific neuronal lineages in the endocrine 
hypothalamus and the subsequent loss of the 
posterior pituitary gland (Nakai et al., 1995; 
Schonemann et al., 1995; Alvarez-Bolado et al., 
1995). And also, transgenes of POU3F2 and some 
other few factors converted non-neural cells to 
neural cells in vitro (Ambasudhan et al., 2011; 
Lujan et al., 2012; Pang et al., 2011). These results 
indicate that POU3F2 is an indispensable 
transcription factor for neural differentiation and 
generation of normal nervous system, especially 
hypothalamus. There have been a few reports 
regarding the functions of POU3F2 in association 
with tumorigenesis. POU3F2 has been  
demonstrated to be an oncogene in malignant 
melanomas derived from the neuroectodermal cell 
lineage and to accelerate the growth of melanoma 
cells (Cook and Sturm, 2008). POU3F2 are also 
highly expressed in small cell lung cancers and 
closely associated with the cancer specific 
neural/neuroendocrine phenotype (Schreiber et al., 
1992; Ishii et al., 2013; Sakaeda et al., 2013). 
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Identity 
Other names: BRN2, N-Oct3, OCT7, OTF-7, 
OTF7, POUF3, brn-2, oct-7 
HGNC (Hugo): POU3F2 
Location: 6q16.1 
 
Schematic representation of POU3F2 gene and mRNA. The POU3F2 gene is located on the plus strand of 6q16.1 
chromosome. It consists of one exon (4086 bp). 
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Schematic illustrating POU3F2 protein. POU3F2 has poly-glycine and glutamic acid repeat in N-terminal side and POU-
specific domain and homeodomain in C-terminal side. 
 
DNA/RNA 
Description 
POU3F2 is intron-less gene. Coding region is 
located in 5' side of the gene. 
Transcription 
4108 base mRNA, coding sequence is 1332 base. 
There are no reports about transcriptional variant. 
Protein 
Description 
POU3F2 belongs to the Class-III POU transcription 
factor family. All class-III POUs mainly express in 
some part of nervous system and regulate the 
development (Dominguez et al., 2013; Phippard et 
al., 1999). Two DNA binding domain, POU-
specific domain, and homeodomain are conserved 
in POU transcription factor family. 
Expression 
POU3F2 expresses in developing nervous system 
and hypothalamus (Andersen and Rosenfeld, 2001). 
It also localizes in the developing mouse spinal 
cord (Tanaka et al., 2004). 
Localisation 
POU3F2 mainly localizes in nuclei. 
Function 
POU3F2 makes homodimer or heterodimer with 
other transcription factor and recognize specific 
DNA motif. POU3F2 activates the transcription of 
near gene. It is reported that target genes of 
POU3F2 are some neural genes (Blaud et al., 
2004), phosphodiesterase 5A (Arozarena et al., 
2011), cadherin 13 (Ellmann et al., 2012), NKX2.1 
(Sakaeda et al., 2013). 
Homology 
POU3F2 shows highly similarity with the other 
class-III POU proteins (POU3F1, POU3F3, 
POU3F4) especially in the DNA binding domain. 
Mutations 
Note 
There is no report about mutation of POU3F2. 
Implicated in 
Melanoma 
Note 
POU3F2 is highly expressed in melanoma cells and 
is related to the tumorigenesis and the growth 
(Cook and Sturm, 2008).  
Suppression of POU3F2 reduced proliferation 
activity and tumorigenic potential of melanoma 
cells (Thomson et al., 1995).  
It is reported that high POU3F2 expression is due to 
the activation of MAPK signaling pathway 
associated with BRAF gene mutation (Goodall et 
al., 2004). 
Small cell lung cancer 
Note 
Small cell lung cancer (SCLC) highly expresses 
POU3F2 compared with non-SCLC. POU3F2 
induces several neuroendocrine specific 
transcription factors and marker molecules and is 
associated to the cell viability (Schreiber et al., 
1992; Ishii et al., 2013; Sakaeda et al., 2013). 
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